Delay in reforming European rules could deny thousands of children access to latest cancer drugs

Thousands of children with cancer across Europe could miss out on the latest targeted treatments because of delays reforming outdated regulations, leading cancer research institutions, charities and expert bodies are warning.
Institute of Cancer Research